Rt. Bustami et al., Generation of micro-particles of proteins for aerosol delivery using high pressure modified carbon dioxide, PHARM RES, 17(11), 2000, pp. 1360-1366
Purpose. To investigate the feasibility of using the Aerosol Solvent Extrac
tion System (ASES) to generate microparticles of proteins suitable for aero
sol delivery from aqueous-based solutions.
Methods. The ASES technique using high- pressure carbon dioxide modified wi
th ethanol was utilised for the generation of microparticles of proteins (l
ysozyme, albumin, insulin and recombinant human deoxyribonuclease (rhDNase)
) from aqueous solutions. Particle size, morphology, size distributions and
powder aerosol performance were examined. The biochemical integrity of the
processed proteins was assessed by testing the level of molecular aggregat
ion using size exclusion chromatography and by bioassay technique for lysoz
yme.
Results. Proteins were precipitated as spherical particles ranging in size
from 100 to 500 nm. The primary nano-sized particles agglomerated to form m
icron-sized particles during the precipitation process. The median size of
the particles was a function of the operating conditions. In-vitro aerosol
performance tests showed that the percent fine particle mass (< 5<mu>m) was
approximately 65%, 40% and 20% for lysozyme, albumin and insulin, respecti
vely. Negligible loss in the monomer content or biological activity was obs
erved for lysozyme. Insulin exhibited slight aggregation and 93% of the mon
omer was retained after processing. Albumin was affected by processing and
only 50-75% of the monomer was retained compared with 86% in the original m
aterial. However, rhDNase was substantially denatured during processing as
shown by the significantly reduced monomer content.
Conclusions. Micron-sized particles of lysozyme, albumin and insulin with s
atisfactory inhalation performance were successfully generated from aqueous
solutions using the modified ASES technique. The biochemical integrity of
the processed proteins was a function of the operating conditions and the n
ature of the individual protein.